Real Money authors - Bret Jensen

Bret Jensen

Bret Jensen was chief investment strategist from 2008-2011 for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami. The fund was in top 5% of long/short hedge funds for total return in its first full year (2009) as ranked by Hedgeco fund database (more than 450 funds in category). Jensen has nearly 20 years of experience in the financial services industry, including more than a decade of managerial experience at American Express. He holds a Bachelor of Science degree in finance from Arizona State University. His personal blog is at Jensen acts as corporate secretary for Florida Alternative Investment Association, which encompasses more than 100 managers managing more than $30 billion in assets under management. Follow Bret on Twitter: @Bret_Jensen.
Email Bret Jensen

Recent Articles By The Author

3 Biotech Stocks Boasting Earnings Beats - and Healthy Outlooks

Quick takes on fourth-quarter results from these 3 biotech names.

Roche Deal for Spark Therapeutics Shows Biotech M&A Spark Hasn't Died

Acquisition deals for biotech companies at the start of 2019 are giving the sector a nice boost; here are other names that could be merger candidates.

These 2 Stocks Illustrate Why Earnings Results Are Better Than Headline Numbers

Stocks can easily trade down more than 10% instantaneously on a headline 'miss'.

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Here Comes the (Long) Weekend

It was great to sit in for Doug Kass on the Daily Diary today. There was a lot of lively commentary on the market, Amazon's pullout from NYC and politics. Stocks ended up nicely across the board as we head into the long holiday weekend. Hopefully ne...

Good News Ahead of the 3-Day Weekend

Not much movement in the overall indices since our last update. Solid day for the markets as trade talks seem to be advancing, and hopefully investors will see some sort of deal in the near future. This would remove a major overhang for the markets ...

Stocks Higher, U.S./China Progress, FDA and Drug Development

Stocks are pretty level to where they were an hour into the open. Even contentious press coverage as President Trump announced a national emergency for additional border measures could not derail the rally very much. Markets are now banking on a mem...

Amazon Quits New York and the Fallout Is Intense

Progress in trade talks between the U.S. and China is enough to overcome some disappointing reads on the economy (December retail sales, January industrial production). The Dow is up over 300 points in early going as we try to close out the trading ...

Newell Sinks, Gold Companies Mixed

Pre-market futures have crept up over the past hour, mainly on some encouraging signs around the U.S./China talks which likely will get more serious as they continue in Washington next week. Brexit talks continue to hit consistent hiccups which is i...

I Like These 2 Smaller Name Biotech Stocks

I still believe it will be a big year for buyouts across the biotech industry.

Email sent

Thank you, your email to has been sent successfully.


We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight